JOURNAL OF CLINICAL NEUROSCIENCE is an esteemed publication dedicated to advancing the field of neurology and related medical disciplines. Published by ELSEVIER SCI LTD, this journal serves as a vital resource for researchers, clinicians, and educators, providing a platform for the dissemination of high-quality research findings since its inception in 1994. With a noteworthy impact factor and ranked within the Q2 and Q3 categories across various medical specialties, including neurology and surgery, the journal positions itself at the forefront of clinical neuroscience. Although it operates under a traditional subscription model, the journal’s commitment to publishing rigorous scientific work ensures that it remains an integral reference for anyone involved in the diagnosis, treatment, and understanding of neurological disorders. Readers can access a diverse array of articles that not only highlight current research trends but also foster the exchange of innovative ideas in clinical practice.

Therapeutic Advances in Neurological Disorders, published by SAGE Publications Ltd, is a leading open access journal dedicated to the advancement of knowledge in the field of neurology. Since its inception in 2008, this journal has established itself as a vital resource for researchers, healthcare professionals, and students, offering a platform for the dissemination of high-quality research that improves the understanding and treatment of neurological disorders. With a commendable impact factor and ranked Q1 in multiple categories, including Neurology and Pharmacology for 2023, it exemplifies excellence in scholarly contributions. The journal's Scope encompasses a wide array of topics, providing insights that are pivotal for clinical practice and pharmacological development. Additionally, with its commitment to open access since 2017, Therapeutic Advances in Neurological Disorders ensures that its research reaches a global audience, fostering collaboration and innovation in neurological science.

Brazilian Neurosurgery-Arquivos Brasileiros de Neurocirurgia, published by GEORG THIEME VERLAG KG, is a distinguished peer-reviewed open access journal that has been making significant contributions to the field of neurosurgery since its transition to open access in 2015. This Brazilian journal, which is accessible to a global audience, aims to disseminate high-quality research articles, reviews, and case reports that enhance the understanding and practice of neurosurgery and clinical neurology. Despite its current ranking in the Q4 category for both neurology and surgery in 2023, the journal is committed to improving its impact and accessibility for researchers, medical professionals, and students worldwide. As an important platform for innovative ideas and discussions, it takes pride in publishing scientifically rigorous content that informs and shapes the future of neurosurgical practices. With the rise of open access publishing, Brazilian Neurosurgery aligns itself with contemporary trends, making vital research readily available to its diverse readership while nurturing academic collaborations within the neurosurgical community.

Clinical Lung Cancer is a prestigious journal published by CIG MEDIA GROUP, LP, dedicated to advancing the field of oncology and pulmonary medicine since its establishment in 2000. With an impressive impact factor and high ranking within its fields—achieving Q1 status in Oncology and Pulmonary and Respiratory Medicine in 2023—this journal serves as a vital resource for researchers, clinicians, and students alike. Covering a wide scope of topics related to lung cancer, Clinical Lung Cancer offers a platform for innovative studies, clinical trials, and comprehensive reviews that contribute to both theory and practice. While it operates on a subscription basis, the quality of content is reflected in its ranked status within the top quartile of cancer research journals. This journal plays a critical role in shaping the future of lung cancer research and treatment, making it an essential destination for those looking to stay at the forefront of the field.

Neuro-Oncology Practice is a leading journal in the interdisciplinary field of neuro-oncology, published by Oxford University Press. With an ISSN of 2054-2577 and E-ISSN 2054-2585, this journal provides a critical platform for the dissemination of cutting-edge research and clinical advancements since its inception in 2014. As of 2023, it has achieved a Q2 ranking in Medicine (Miscellaneous), Neurology, and Oncology categories, reflecting its esteemed position in the academic community with impressive Scopus rankings, including a 74th percentile in the field of Medicine. Despite its non-open access status, Neuro-Oncology Practice aims to bridge the gap between laboratory research and clinical practice, offering valuable insights for professionals involved in the treatment and study of neurological cancers. The journal actively encourages submissions that explore innovative treatment strategies, enhance patient care, and advance our understanding of the complexities surrounding brain tumors. With a convergence period extending to 2024, it remains a crucial resource for researchers, practitioners, and students who are committed to improving outcomes in the field of neuro-oncology.

Brain and Spine is a premier academic journal published by ELSEVIER, dedicated to advancing the fields of neuroscience and neurology. With its unique focus on the complex interactions between brain function and spinal health, this journal serves as an essential resource for researchers, clinicians, and students alike. Though currently lacking an official impact factor, its ranking within Scopus highlights its relevance, placing it in the 25th percentile for neuroscience (miscellaneous) and the 23rd percentile within neurology, indicating that while it is a developing journal, it holds potential for significant contributions to the field. Operating under open-access principles, it aims to disseminate valuable findings widely, ensuring that novel insights into neurological health are accessible to a global audience. Brain and Spine seeks to foster interdisciplinary collaboration and innovation, making it an invaluable platform for those striving to enhance our understanding of the brain and spinal cord's intricate functions and interdependencies.

CLINICAL NEUROLOGY AND NEUROSURGERY, published by Elsevier, is a pivotal journal in the fields of neurology and neurosurgery, recognized for its rigorous peer-review process and commitment to advancing clinical practices. Established in 1974, the journal has become a respected source of innovative research, evidenced by its excellent Scopus rankings—placing it within the top half of journals in both Medicine (Surgery) and the clinical aspect of Neurology. Notably, it has achieved a Q2 ranking in both Medicine (miscellaneous) and Surgery, and Q3 in Neurology (clinical) as of 2023. The journal publishes a wide array of articles focused on the latest findings, clinical practices, and technological advancements that address neurological disorders and surgical interventions. While it does not currently operate under an open-access model, it remains highly accessible to academic institutions and professionals worldwide from its editorial base in the Netherlands. By enabling knowledge-sharing and fostering collaboration among researchers, practitioners, and students, CLINICAL NEUROLOGY AND NEUROSURGERY plays a crucial role in shaping the future of clinical neurology and surgical techniques.

Therapeutic Advances in Medical Oncology, an esteemed journal published by SAGE Publications Ltd, serves as a critical platform for disseminating high-quality research pertinent to the field of oncology. Indexed under the ISSN 1758-8340 and E-ISSN 1758-8359, this Open Access journal has made significant strides since its inception in 2009, attaining a commendable rank of #78 out of 404 in the Medicine - Oncology category of Scopus, placing it in the top 20th percentile of journals. With its category quartile of Q1 established in 2023, it underscores the journal’s commitment to advancing therapeutic approaches in oncology, making it an invaluable resource for researchers, clinicians, and students alike. Offering unrestricted access to pioneering studies since 2017, it aligns with the global movement towards open science, fostering collaboration and innovation among professionals striving to improve cancer treatment outcomes. By bridging the gap between research and clinical practice, Therapeutic Advances in Medical Oncology plays a vital role in shaping the future of cancer therapy.

Neurosurgical Focus, an esteemed journal published by the American Association of Neurological Surgeons, stands at the forefront of neurosurgical research and clinical practice. With its ISSN 1092-0684, this peer-reviewed publication has made a significant impact in the fields of Medicine, Neurology, and Surgery, consistently ranking in the top quartile (Q1) across these categories based on the 2023 metrics. The journal, which spans a rich temporal landscape from 2000 to 2024, offers a platform for disseminating vital research findings, insightful reviews, and innovative surgical techniques. While it is not open access, its high Scopus rankings—40th out of 551 in Medicine & Surgery and 97th out of 400 in Neurology—highlight its broader influence and the quality of research it curates. As an essential resource for researchers, clinicians, and students, Neurosurgical Focus is dedicated to advancing the field of neurosurgery and fostering intellectual discourse within the community.

Brain Tumor Pathology is a pivotal peer-reviewed journal published by SPRINGER JAPAN KK, focusing on the intricate and evolving field of brain tumor research. Established in 1997, the journal serves as a crucial platform for disseminating research findings, clinical studies, and reviews that advance our understanding of brain tumors and their pathology. With a notable impact factor, it ranks in the Q2 and Q3 quartiles in multiple categories, including Cancer Research, Medicine (miscellaneous), Neurology (clinical), and Oncology, reflecting its significance in enhancing scientific discourse and clinical practice. The journal is indexed by major databases, making it accessible to a wide audience of researchers, clinicians, and students who are dedicated to unraveling the complex mechanisms of brain tumors. Although it does not currently offer open access, its comprehensive articles and studies contribute to the vital conversation on brain tumor pathologies, treatment prospects, and innovation in the field. Researchers and professionals alike will find the insights and advancements presented in Brain Tumor Pathology indispensable for guiding future studies and improving clinical outcomes.